Clinical trial · Observational
Nasopharyngeal Carcinoma Screening in Zhongshan City
Serology Screening Test for the Detection of Nasopharyngeal Carcinoma in Zhongshan City
NCT02501993CI-TRIAL-00067985unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The primary objective is to determine the early diagnosis rate and mortality rate of the Nasopharyngeal Carcinoma (NPC) in the study population. The secondary objective is to determine the incidence of NPC in the study population.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Nasopharyngeal Carcinoma | Nasopharyngeal Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Screening cohort
- description
- All participants will be tested for anti-EBV antibody by using serum samples. Participants are stratified into those having high, moderate and low antibody levels, those having moderate antibody levels are invited to retest annually in the following 3 years and those found to have high antibody levels on these occasions are referred to centers for diagnostic workup for NPC.
Primary outcomes (2)
- measure
- The early detection rate (stage I and II) of Nasopharyngeal Carcinoma
- timeFrame
- 10 years
- measure
- The mortality rate of Nasopharyngeal Carcinoma
- timeFrame
- 10 years
Secondary outcomes (1)
- measure
- The incidence of Nasopharyngeal Carcinoma
- timeFrame
- 10 years
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 30 Years
- Maximum age
- 59 Years
Show eligibility criteria text
Inclusion Criteria: * Subject residents in Zhongshan city * Subject is 30 to 59 years of age inclusive * Subject has no medical record of nasopharyngeal carcinoma * ECOG 0-2 * Subject has psychical condition and well consciousness * Subject is able to comprehend, sign, and date the written informed consent document to participate in the study. Exclusion Criteria: * Subject has heavy cardiovascular, liver or kidney disease * Subject has medical record of nasopharyngeal carcinoma * Subject who is not residing in Zhongshan City
References
Publications (0)
Data not yet available
No reference posted for this study.